250 related articles for article (PubMed ID: 4935790)
1. Combination therapy with cyclophosphamide, vincristine, procarbazine and prednisone in Hodgkin's disease and reticulum cell sarcoma.
Isola LM; Cremerius de Sica SM; Palau M; Pereyra MA; Alzugaray AE
Medicina (B Aires); 1971; 31(2):93-7. PubMed ID: 4935790
[No Abstract] [Full Text] [Related]
2. Combination chemotherapy of advanced lymphomas.
Kurnick JE; Robinson WA
Arch Intern Med; 1972 Jun; 129(6):908-13. PubMed ID: 5067727
[No Abstract] [Full Text] [Related]
3. Status and perspectives in chemotherapy of Hodgkin's disease.
Frei E
Arch Intern Med; 1973 Mar; 131(3):439-45. PubMed ID: 4739436
[No Abstract] [Full Text] [Related]
4. [Multiple drug therapy in Hodgkin's disease, lymphosarcoma and reticulosarcoma].
Con I; Daiber A; Donoso A; Osorio G; Mora F
Rev Med Chil; 1972 Apr; 100(4):408-13. PubMed ID: 4557485
[No Abstract] [Full Text] [Related]
5. Combined cyclophosphamide vincristine, procarbazine, and prednisone (COPP) therapy of malignant lymphoma. Evaluation of 190 patients.
Morgenfeld MC; Pavlovsky A; Suarez A; Somoza N; Pavlovsky S; Palau M; Barros CA
Cancer; 1975 Oct; 36(4):1241-9. PubMed ID: 1100220
[TBL] [Abstract][Full Text] [Related]
6. [Combination chemotherapy and synchronization therapy in lymphogranulomatosis and non-Hodgkin's lymphomas].
Klein HO
Hamatol Bluttransfus; 1976; 18():135-45. PubMed ID: 786808
[No Abstract] [Full Text] [Related]
7. Proceedings: Malignant lymphoma: treatment with combination chemotherapy.
De Vita VT; Canellos GP; Schein PJ; Chabner BA; Bagley CM; Young RC
Proc Natl Cancer Conf; 1972; 7():379-90. PubMed ID: 4587651
[No Abstract] [Full Text] [Related]
8. Combination chemotherapy with nitrogen mustard, vincristine, procarbazine and prednisone in previously treated patients with Hodgkin's disease.
Lowenbraun S; DeVita VT; Serpick AA
Blood; 1970 Dec; 36(6):704-17. PubMed ID: 5488687
[No Abstract] [Full Text] [Related]
9. [Results of the synchronization therapy with vincristine and cyclophosphamide in lymphogranulomatosis, reticulum cell sarcoma and lymphosarcoma. A phase II study (author's transl)].
Klein HO; Gerecke D; Borberg H; Gross R; Hoefer-Janker H; Scheef W; Diehl V; Lohmann E; Adler D; Buter E; Löhning A; Brock N; Burkert H
Dtsch Med Wochenschr; 1975 Aug; 100(35):1719-26. PubMed ID: 1098886
[TBL] [Abstract][Full Text] [Related]
10. [Association of nitrogen mustard, vincristine, methylhydrazine and prednisone in treatment of diffuse forms of Hodgkin's disease and ganglionic sarcomas].
Goudemand M; Sautière-Habay D; Bauters F; Lerche-Habart B
Lille Med; 1968 Dec; 13(10):1102-7. PubMed ID: 4886051
[No Abstract] [Full Text] [Related]
11. Management of patients with non-Hodgkin's lymphoma.
Carbone PP
Arch Intern Med; 1973 Mar; 131(3):455-9. PubMed ID: 4569377
[No Abstract] [Full Text] [Related]
12. Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group.
Behringer K; Breuer K; Reineke T; May M; Nogova L; Klimm B; Schmitz T; Wildt L; Diehl V; Engert A;
J Clin Oncol; 2005 Oct; 23(30):7555-64. PubMed ID: 16234521
[TBL] [Abstract][Full Text] [Related]
13. Combined chemotherapy and radiotherapy for advanced Hodgkin's disease and reticulum cell sarcoma: a preliminary report.
Gamble JF; Fuller LM; Butler JJ; Shullenberger CC
South Med J; 1971 Jul; 64(7):775-83. PubMed ID: 4933012
[No Abstract] [Full Text] [Related]
14. Single-agent therapy for Hodgkin's disease.
Carter SK; Livingston RB
Arch Intern Med; 1973 Mar; 131(3):377-87. PubMed ID: 4631683
[No Abstract] [Full Text] [Related]
15. Chemotherapy of the lymphomas.
McElwain TJ
Semin Hematol; 1974 Jan; 11(1):59-72. PubMed ID: 4859700
[No Abstract] [Full Text] [Related]
16. [Preliminary analysis of results of chemotherapy in patients with proliferative disease of the lymphatic system with the exclusion of Hodgkin's disease using vincristine, cyclophosphamide and prednisone].
Zelechowska JA; Leszczyk C; Madej G; Pieńkowska F; Nozdryn-Plotnicki B
Pol Tyg Lek; 1977 Aug; 32(34):1329-31. PubMed ID: 905177
[No Abstract] [Full Text] [Related]
17. Long-term follow-up of patients with intermediate or high-grade non-Hodgkin lymphoma treated with a combination of cyclophosphamide, epirubicin, vincristine, and prednisone.
Rossini F; Terruzzi E; Perego D; Miccolis I; Rivolta F; Manca E; Pogliani EM
Cancer; 2004 Jan; 100(2):350-5. PubMed ID: 14716771
[TBL] [Abstract][Full Text] [Related]
18. Procarbazine hydrochloride (Matulane) for Hodgkin's disease.
Med Lett Drugs Ther; 1970 Aug; 12(17):72. PubMed ID: 5514228
[No Abstract] [Full Text] [Related]
19. Splenectomy effects on chemotherapy in Hodgkin's disease.
Panettiere F; Coltman CA
Arch Intern Med; 1973 Mar; 131(3):362-6. PubMed ID: 4688035
[No Abstract] [Full Text] [Related]
20. 14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group.
Sieber M; Bredenfeld H; Josting A; Reineke T; Rueffer U; Koch T; Naumann R; Boissevain F; Koch P; Worst P; Soekler M; Eich H; Müller-Hermelink HK; Franklin J; Paulus U; Wolf J; Engert A; Diehl V;
J Clin Oncol; 2003 May; 21(9):1734-9. PubMed ID: 12721249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
